GBP5 and metastatic malignant neoplasm in the lymph nodes: This study found that the high expression levels of GBP5 are associated with cancer malignancy and poor prognosis in oral cancer patients with poor cell differentiation and lymph node metastasis, indicating that GBP5 might play an oncogenic role in OSCC.